Diagnos Inc. (“DIAGNOS” or the “Company”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of critical health issues, is pleased to announce that it has entered into a Memorandum of Understanding (MoU) with the Instruments division of Essilor International, a subsidiary of EssilorLuxottica. Essilor International is the world’s leading ophthalmic optics… Continue reading Diagnos $ADK #DGNOF Signs Memorandum of Understanding with #Essilor International
Tag: USA
Diagnos $ADK $DGNOF Initiates a Clinical Trial Study in the USA for Early Detection and Prevention of Stroke Using it new Application CARA-STROKE
Diagnos Inc. (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues, announces today the initiation of a clinical trial study with CommonSpirit Health Research Institute, Chattanooga Center for Neurologic Research LLC and conducted at the CommonSpirit Hospital in Chattanooga, to confirm early Proof-of-Concept results that showed a strong potential in… Continue reading Diagnos $ADK $DGNOF Initiates a Clinical Trial Study in the USA for Early Detection and Prevention of Stroke Using it new Application CARA-STROKE